UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer

Cancer research (Chicago, Ill.), 2011-08, Vol.71 (16), p.5423-5434

2011

Link zum Volltext

Verfügbarkeit prüfen

Validation of prognostic scores for survival in cancer patients beyond first-line therapy

BMC cancer, 2011-03, Vol.11 (1), p.95-95, Article 95

2011

Link zum Volltext

Verfügbarkeit prüfen

Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial

BMC cancer, 2012-12, Vol.12 (1), p.603-603, Article 603

2012

Link zum Volltext

Verfügbarkeit prüfen

Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence

Radiation oncology (London, England), 2012-03, Vol.7 (1), p.46-46, Article 46

2012

Link zum Volltext

Verfügbarkeit prüfen

Outcome of recurrent and metastatic small cell carcinoma of the bladder

BMC urology, 2009-06, Vol.9 (1), p.4-4, Article 4

2009

Link zum Volltext

Verfügbarkeit prüfen

Impaired IFN-α Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression

Cancer research (Chicago, Ill.), 2012-10, Vol.72 (20), p.5188-5197

2012

Link zum Volltext

Verfügbarkeit prüfen

Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer

BMC research notes, 2010-06, Vol.3 (1), p.164-164, Article 164

2010

Link zum Volltext

Verfügbarkeit prüfen

An in silico approach helped to identify the best experimental design, population, and outcome for future randomized clinical trials

Journal of clinical epidemiology, 2016-01, Vol.69, p.125-136

2016

Link zum Volltext

Verfügbarkeit prüfen

Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome

European journal of cancer (1990), 2013-05, Vol.49 (7), p.1673-1682

2013

Link zum Volltext

Verfügbarkeit prüfen

Experimental designs for small randomised clinical trials: an algorithm for choice

Orphanet journal of rare diseases, 2013-03, Vol.8 (1), p.48-48

2013

Link zum Volltext

Verfügbarkeit prüfen

A methodological framework for drug development in rare diseases

Orphanet journal of rare diseases, 2014-11, Vol.9 (1), p.164-164, Article 164

2014

Link zum Volltext

Verfügbarkeit prüfen

Model of mucociliary clearance in cystic fibrosis lungs

Journal of theoretical biology, 2015-05, Vol.372, p.81-88

2015

Link zum Volltext

Verfügbarkeit prüfen

Dynamic changes of depolarizing GABA in a computational model of epileptogenic brain: Insight for Dravet syndrome

Experimental neurology, 2016-09, Vol.283 (Pt A), p.57-72

2016

Link zum Volltext

Verfügbarkeit prüfen

Physiologically based pharmacokinetic model for 6‐mercpatopurine: exploring the role of genetic polymorphism in TPMT enzyme activity

British journal of clinical pharmacology, 2015-07, Vol.80 (1), p.86-100

2015

Link zum Volltext

Verfügbarkeit prüfen

Mathematical model of T-cell lymphoblastic lymphoma: disease, treatment, cure or relapse of a virtual cohort of patients

Mathematical medicine and biology, 2018-03, Vol.35 (1), p.25-47

2018

Link zum Volltext

Verfügbarkeit prüfen

Body weight change in women receiving adjuvant chemotherapy for breast cancer: A French prospective study

Clinical nutrition (Edinburgh, Scotland), 2010-04, Vol.29 (2), p.187-191

2010

Link zum Volltext

Verfügbarkeit prüfen

A physiologically based pharmacokinetic model for Valproic acid in adults and children

European journal of pharmaceutical sciences, 2014-10, Vol.63, p.45-52

2014

Link zum Volltext

Verfügbarkeit prüfen

A Physiologically Based Pharmacokinetic Model for Clobazam and Stiripentol in Adults and Children

Pharmaceutical research, 2015-01, Vol.32 (1), p.144-157

2015

Link zum Volltext

Verfügbarkeit prüfen

Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexate

Journal of pharmacokinetics and pharmacodynamics, 2014-04, Vol.41 (2), p.159-171

2014

Link zum Volltext

Verfügbarkeit prüfen

Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate

Journal of pharmacokinetics and pharmacodynamics, 2014-04, Vol.41 (2), p.173-185

2014

Link zum Volltext

Verfügbarkeit prüfen

A candidate molecular signature associated with tamoxifen failure in primary breast cancer

Breast cancer research : BCR, 2008-01, Vol.10 (5), p.R88-R88, Article R88

2008

Link zum Volltext

Verfügbarkeit prüfen

Final Results of ERASME-4: A Randomized Trial of First-Line Docetaxel plus either Capecitabine or Epirubicin for Metastatic Breast Cancer

Oncology, 2011-01, Vol.80 (3-4), p.262-268

2011

Link zum Volltext

Verfügbarkeit prüfen

Permanent .sup.125.sup.I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence

Radiation oncology (London, England), 2012-03, Vol.7, p.46

2012

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Primary CNS Lymphoma in the Elderly with High-Dose Methotrexate Containing Chemotherapy Followed Radiotherapy or Chemotherapy Alone Plus Deferred Radiotherapy: Evaluation of Modification of Treatment Modalities in Leon Berard Cancer Center

Blood, 2009-11, Vol.114 (22), p.2702-2702

2009

Link zum Volltext

Verfügbarkeit prüfen

Revisiting the level of evidence in randomized controlled clinical trials: A simulation approach

Contemporary clinical trials, 2009-09, Vol.30 (5), p.400-410

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer

Validation of prognostic scores for survival in cancer patients beyond first-line therapy

Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial

Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence

Outcome of recurrent and metastatic small cell carcinoma of the bladder

Impaired IFN-α Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression

Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer

An in silico approach helped to identify the best experimental design, population, and outcome for future randomized clinical trials

Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome

Experimental designs for small randomised clinical trials: an algorithm for choice

A methodological framework for drug development in rare diseases

Model of mucociliary clearance in cystic fibrosis lungs

Dynamic changes of depolarizing GABA in a computational model of epileptogenic brain: Insight for Dravet syndrome

Physiologically based pharmacokinetic model for 6‐mercpatopurine: exploring the role of genetic polymorphism in TPMT enzyme activity

Mathematical model of T-cell lymphoblastic lymphoma: disease, treatment, cure or relapse of a virtual cohort of patients

Body weight change in women receiving adjuvant chemotherapy for breast cancer: A French prospective study

A physiologically based pharmacokinetic model for Valproic acid in adults and children

A Physiologically Based Pharmacokinetic Model for Clobazam and Stiripentol in Adults and Children

Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexate

Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate

A candidate molecular signature associated with tamoxifen failure in primary breast cancer

Final Results of ERASME-4: A Randomized Trial of First-Line Docetaxel plus either Capecitabine or Epirubicin for Metastatic Breast Cancer

Permanent .sup.125.sup.I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence

Treatment of Primary CNS Lymphoma in the Elderly with High-Dose Methotrexate Containing Chemotherapy Followed Radiotherapy or Chemotherapy Alone Plus Deferred Radiotherapy: Evaluation of Modification of Treatment Modalities in Leon Berard Cancer Center

Revisiting the level of evidence in randomized controlled clinical trials: A simulation approach

Suchergebnisse filtern